BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 11344835)

  • 21. Weekly paclitaxel for advanced aggressive classic Kaposi sarcoma: experience in 17 cases.
    Brambilla L; Romanelli A; Bellinvia M; Ferrucci S; Vinci M; Boneschi V; Miedico A; Tedeschi L
    Br J Dermatol; 2008 Jun; 158(6):1339-44. PubMed ID: 18363766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vinorelbine therapy in classic Kaposi's sarcoma: a retrospective study of 20 patients.
    Brambilla L; Recalcati S; Tourlaki A
    Eur J Dermatol; 2015; 25(6):535-8. PubMed ID: 26552718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous infusion etoposide in advanced AIDS-related kaposi sarcoma.
    Remick SC; Reddy M; Ekman K; Vyzula R; Hilstro J; Horton J
    J Infus Chemother; 1996; 6(2):92-6. PubMed ID: 8809657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A retrospective analysis of thalidomide therapy in non-HIV-related Kaposi's sarcoma.
    Ben M'barek L; Fardet L; Mebazaa A; Thervet E; Biet I; Kérob D; Morel P; Lebbe C
    Dermatology; 2007; 215(3):202-5. PubMed ID: 17823515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful treatment of liver transplant-associated Kaposi's sarcoma with long-term vincristine.
    Akay S; Karasu Z; Akyildiz M; Tokat Y; Goker E
    Transplant Proc; 2005 Jun; 37(5):2188-9. PubMed ID: 15964375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paclitaxel for AIDS-associated Kaposi's sarcoma.
    Dhillon T; Stebbing J; Bower M
    Expert Rev Anticancer Ther; 2005 Apr; 5(2):215-9. PubMed ID: 15877519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vinblastine therapy of Kaposi's sarcoma.
    Goldman J; Greenwald ES; Schulman PL
    N Y State J Med; 1974 Sep; 74(10):1828-31. PubMed ID: 4528855
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of recurrent Kaposi's sarcoma of an AIDS patient with weekly paclitaxel.
    Hsu CH; Chen MY; Cheng AL
    Anticancer Res; 2000; 20(2B):1159-61. PubMed ID: 10810414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase III study of intravenous vinorelbine in combination with epirubicin versus epirubicin alone in patients with advanced breast cancer: a Scandinavian Breast Group Trial (SBG9403).
    Ejlertsen B; Mouridsen HT; Langkjer ST; Andersen J; Sjöström J; Kjaer M;
    J Clin Oncol; 2004 Jun; 22(12):2313-20. PubMed ID: 15197192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of intralesional vinblastine administration in treatment of intraoral Kaposi's sarcoma in AIDS.
    Flaitz CM; Nichols CM; Hicks MJ
    Eur J Cancer B Oral Oncol; 1995 Jul; 31B(4):280-5. PubMed ID: 7492927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vinblastine therapy for Kaposi's sarcoma in the acquired immunodeficiency syndrome.
    Volberding PA; Abrams DI; Conant M; Kaslow K; Vranizan K; Ziegler J
    Ann Intern Med; 1985 Sep; 103(3):335-8. PubMed ID: 4026082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiotherapy of classic Kaposi's sarcoma in Taiwan, an area where classic Kaposi's sarcoma is not prevalent.
    Huang KM; Hsu CH; Cheng JC; Lai MK; Jeng SC; Ting LL; Huang WT
    Anticancer Res; 2006; 26(6C):4659-63. PubMed ID: 17214323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clearance of recurrent, classical Kaposi's sarcoma using multiple paclitaxel treatments.
    Osawa R; Kato N; Yanagi T; Yamane N
    Acta Derm Venereol; 2007; 87(5):435-6. PubMed ID: 17721656
    [No Abstract]   [Full Text] [Related]  

  • 34. [Intralesional vinblastine in the treatment of Kaposi's sarcoma. Presentation of a case].
    Gaglioti D; Ficarra G; Nardi P
    Minerva Stomatol; 1989 Sep; 38(9):955-7. PubMed ID: 2811811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kaposi's sarcoma in rheumatic diseases.
    Louthrenoo W; Kasitanon N; Mahanuphab P; Bhoopat L; Thongprasert S
    Semin Arthritis Rheum; 2003 Apr; 32(5):326-33. PubMed ID: 12701043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disseminated classic Kaposi's sarcoma. Two cases with excellent response to pegylated liposomal doxorubicin.
    Castiñeiras I; Almagro M; Rodríguez-Lozano J; Fernández-Jorge B; Paradela S; Pozo JD; Fonseca E
    J Dermatolog Treat; 2006; 17(6):377-80. PubMed ID: 17853313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful treatment with three-weekly paclitaxel of an anthracycline-refractory classical Kaposi's sarcoma.
    Silvestris N; Galetta D; Colucci G
    Anticancer Res; 2009 Feb; 29(2):675-6. PubMed ID: 19331220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and pharmacokinetic study of oral etoposide in patients with AIDS-related Kaposi's sarcoma with no prior exposure to cytotoxic therapy.
    Schwartsmann G; Sprinz E; Kromfield M; Kalakun L; Sander E; Prolla G; Di Leone L; Gerhardt L; Mans DR
    J Clin Oncol; 1997 May; 15(5):2118-24. PubMed ID: 9164226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low dose recombinant interferon alfa treatment for classic Kaposi's sarcoma.
    Tur E; Brenner S; Michalevicz R
    Arch Dermatol; 1993 Oct; 129(10):1297-300. PubMed ID: 8215494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.